Long term efficacy of extracorporeal shock wave therapy [ESWT] for treatment of refractory chronic abacterial prostatitis

Ghazi Mohammad Al Edwan, Muheilan Mustafa Muheilan, Omar Nabeeh M Atta, Ghazi Mohammad Al Edwan, Muheilan Mustafa Muheilan, Omar Nabeeh M Atta

Abstract

Objective: To evaluate the effect and safety of extracorporeal shockwave therapy (ESWT) on chronic pelvic pain syndrome (CPPS)/chronic abacterial prostatitis after failure of most other modalities of treatment, the maintenance of the treatment effect for up to one year post treatment and whether the patients are in need for further sessions.

Materials and methods: In a follow-up survey of 41 patients, the study inclusion criteria were CPPS patients who failed at least previously 3 modalities of treatment other than ESWT, who were treated by ESWT once a week for one month with a protocol of 2500 pulses at 1 bar over 13 min, Nonaddiction to drugs and narcotics. The exclusion criteria included being under treatment by another method another diagnosis such as prostate cancer, therapy plan alteration, and noninclination to continue this treatment. Then the patients were followed up at 2 weeks, 6 months and 12 months after finishing the course of ESWT. The study was designed as an open-label uncontrolled therapeutic clinical trial which was conducted in Jordan university hospital through the period 2015-2016. Data were compared using paired samples t-test.

Results: Of our total 55 patients 8 of them did not complete the study protocol, 6 of them had missed follow up over the whole follow up period and 41 patients were evaluated. The patient's age group ranged between 18 and 78 years with a mean age of 42 and a median age of 43. The mean of National Institutes of Health -Chronic Prostatitis Symptom Index (NIH-CPSI), the International Prostate Symptom Score (IPSS), American Urological Association Quality of Life Due to Urinary Symptoms (AUA QOL_US) and International Index of Erectile Function (IIEF) were evaluated pre and post ESWT at 2 weeks, 6 months and 12 months and it showed statistically significant improvement in all parameters with maintenance of the effect without any significant side-effect of the treatment over the 12 months.

Conclusions: The evidence in this study would support the safety and efficacy of ESWT in refractory cases of CPPS at least for one year post treatment.

Keywords: CPPS; Chronic abacterial prostatitis; ESWT; Extracorporeal shock wave therapy; Prostate.

Figures

Fig. 1
Fig. 1
ESWT machine.
Fig. 2
Fig. 2
ESWT probe.
Fig. 3
Fig. 3
Best response IPSS on 12 months.
Fig. 4
Fig. 4
Best response IIEF on 12 months.

References

    1. McNaughton-Collins M., MacDonald R., Wilt T.J. Diagnosis and treatment of chronic abacterial prostatitis: a systematic review. Ann. Intern Med. 2000;133:367–381.
    1. Nickel J.C. Classification and diagnosis of prostatitis: a gold standard? Andrologia. 2003;35:160–167.
    1. McNaughton Collins M., Pontari M.A., O'Leary M.P. Quality of life is impaired in men with chronic prostatitis: the chronic prostatitis collaborative research network. J. Gen. Intern Med. 2001;16:656–662.
    1. Krieger J.N., Nyberg L.J., Nickel J.C. NIH consensus definition and classification of prostatitis. JAMA. 1999;282:236–237.
    1. Weidner W., Anderson R.U. Evaluation of acute and chronic bacterial prostatitis and diagnostic management of chronic prostatitis/chronic pelvic pain syndrome with special reference to infection/inflammation. Int. J. Antimicrob. Agents. 2008;31(Suppl. 1):91–95.
    1. Anothaisintawee T., Attia J., Nickel J.C. Management of chronic prostatitis/chronic pelvic pain syndrome: a systematic review and network meta-analysis. J. Am. Med. Assoc. 2011;305(1):78–86.
    1. Nickel J.C., Downey J., Clark J. Levofloxacin for chronic prostatitis/chronic pelvic pain syndrome in men: a randomized placebo-controlled multicenter trial. Urology. 2003;62(4):614–617.
    1. Nickel J.C., Krieger J.N., McNaughton-Collins M. Alfuzosin and symptoms of chronic prostatitis-chronic pelvic pain syndrome. N. Engl. J. Med. 2008;359(25):2663–2673.
    1. Capodice J.L., Bemis D.L., Buttyan R., Kaplan S.A., Katz A.E. Complementary and alternative medicine for chronic prostatitis/chronic pelvic pain syndrome. Evid. Based Complement. Altern. Med. 2005;2:495–501.
    1. Nickel J.C., Sorensen R. Transurethral microwave thermotherapy for nonbacterial prostatitis: a randomized double-blind sham controlled study using new prostatitis specific assessment questionnaires. J. Urol. 1996;155(6):1950–1955.
    1. Pontari M.A., Ruggieri M.R. Mechanisms in prostatitis/chronic pelvic pain syndrome. J. Urol. 2004;172(3):839–845.
    1. Chow G.K., Streem S.B. Extracorporeal lithotripsy. Update on technology. Urol. Clin. North Am. 2000;27:315–322.
    1. Chow I.H., Cheing G.L. Comparison of different energy densities of extracorporeal shock wave therapy (ESWT) for the management of chronic heel pain. Clin. Rehabil. 2007;21:131–141.
    1. Manganotti P., Amelio E. Long term effect of shock wave therapy on upper limb hypertonia in patients affected by stroke. Stroke. 2005;36:1967–1971.
    1. Krhen I., Skerk V., Schönwald S., Mareković Z. Classification, diagnosis and reatment of prostatitis syndrome. Lijec. Vjesn. 2002;124:89–98.
    1. Lipsky B.A. Prostatitis and urinary tract infection in men: What's new; what's true? Am. J. Med. 1999;106:327–334.
    1. Zimmermann R., Cumpanas A., Miclea F., Janetschek G. Extracorporeal shock wave therapy for the treatment of chronic pelvic pain syndrome inmales: randomised, double-blind, placebo-controlled study. Eur. Urol. 2009 Sep;56(3):418–424.
    1. Zimmermann R., Cumpanas A., Hoeltl L., Janetschek G., Stenzl A., Miclea F. Extracorporeal shock-wave therapy for treating chronic pelvic pain syndrome: a feasibility study and the first clinical results. BJU Int. 2008;102:976–980.
    1. Moayednia Amir, Haghdani Saeid, Khosrawi Saeid, Yousefi Elham, Vahdatpour Babak. Long-term effect of extracorporeal shock wave therapy on the treatment of chronic pelvic pain syndrome due to nonbacterial prostatitis. J. Res. Med. Sci. 2014 Apr;19(4):293–296.
    1. Yan X., Yang G., Cheng L., Chen M., Cheng X., Chai Y. Effect of extracorporeal shock wave therapy on diabetic chronic wound healing and its histological features. Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi. 2012;26:961–967.

Source: PubMed

赞助者和合作者

医疗条件

药物干预

3
订阅